IN2012DN03631A - - Google Patents

Download PDF

Info

Publication number
IN2012DN03631A
IN2012DN03631A IN3631DEN2012A IN2012DN03631A IN 2012DN03631 A IN2012DN03631 A IN 2012DN03631A IN 3631DEN2012 A IN3631DEN2012 A IN 3631DEN2012A IN 2012DN03631 A IN2012DN03631 A IN 2012DN03631A
Authority
IN
India
Prior art keywords
canines
eye
carotenes
amounts
maladies
Prior art date
Application number
Other languages
English (en)
Inventor
Yuanlong Pan
Wei Wang
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of IN2012DN03631A publication Critical patent/IN2012DN03631A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN3631DEN2012 2009-10-30 2010-10-22 IN2012DN03631A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28017509P 2009-10-30 2009-10-30
PCT/US2010/002815 WO2011059474A1 (fr) 2009-10-30 2010-10-22 Procédés de maintien de la santé oculaire et d'amélioration des maladies ophtalmiques chez les canidés

Publications (1)

Publication Number Publication Date
IN2012DN03631A true IN2012DN03631A (fr) 2015-06-26

Family

ID=43991896

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3631DEN2012 IN2012DN03631A (fr) 2009-10-30 2010-10-22

Country Status (12)

Country Link
US (1) US20120270954A1 (fr)
EP (1) EP2493293B1 (fr)
JP (1) JP6071554B2 (fr)
CN (1) CN102686107A (fr)
AU (1) AU2010318687B2 (fr)
BR (1) BR112012010179A2 (fr)
CA (1) CA2778229A1 (fr)
ES (1) ES2566652T3 (fr)
IN (1) IN2012DN03631A (fr)
MX (1) MX2012004777A (fr)
RU (1) RU2012122169A (fr)
WO (1) WO2011059474A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6026719B2 (ja) * 2010-08-31 2016-11-16 株式会社ダイセル 視機能予防・改善剤
WO2013043366A1 (fr) * 2011-09-20 2013-03-28 Nestec S.A. Méthodes et compositions permettant d'améliorer la fonction visuelle et la santé oculaire

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2094060C1 (ru) * 1994-03-22 1997-10-27 Уфимский научно-исследовательский институт глазных болезней Глазная мазь
NZ527924A (en) * 1999-01-29 2005-01-28 Mars Uk Ltd Antioxidant compositions and methods for companion animals
US20020110604A1 (en) * 2000-08-11 2002-08-15 Ashni Naturaceuticals, Inc. Composition exhibiting synergistic antioxidant activity
US20020182736A1 (en) * 2001-04-02 2002-12-05 Trustees Of Tufts College Methods to measure lipid antioxidant activity
CA2484512C (fr) 2002-05-17 2013-04-16 Othera Pharmaceuticals, Inc. Traitement de cataractes et d'autres maladies opthalmiques
ES2354971T3 (es) 2002-05-28 2011-03-21 Nycomed Gmbh Uso oftalmológico de roflumilast para el tratamiento de enfermedades de los ojos.
WO2005087208A2 (fr) * 2004-03-10 2005-09-22 Trustees Of Tufts College Effet synergique des caroténoïdes
EP1778207A2 (fr) * 2004-08-18 2007-05-02 Sytera Inc. Compositions combinees avec derives de 13-cis-retinyle et leur utilisation pour le traitement des etats ophtalmiques
WO2006116755A2 (fr) * 2005-04-28 2006-11-02 Trustees Of Tufts College Effets synergiques de l'acide docosahexaenoique (dha) et de l'absorbtion de carotenoides sur les fonctions cognitives
JP2009538353A (ja) * 2006-06-08 2009-11-05 ザ アイムス カンパニー 眼の健康を増進するための組成物
US8158667B2 (en) 2006-08-21 2012-04-17 Kador Peter F Topical treatment of cataracts in dogs
JPWO2009051223A1 (ja) 2007-10-19 2011-03-03 株式会社アールテック・ウエノ 白内障処置のための医薬組成物
JP2011510684A (ja) * 2008-02-06 2011-04-07 ザ プロクター アンド ギャンブル カンパニー 呼吸器状態に対する免疫反応を強化するための組成物、方法、及びキット

Also Published As

Publication number Publication date
EP2493293B1 (fr) 2016-03-02
JP6071554B2 (ja) 2017-02-01
EP2493293A1 (fr) 2012-09-05
ES2566652T3 (es) 2016-04-14
BR112012010179A2 (pt) 2015-09-29
WO2011059474A1 (fr) 2011-05-19
CA2778229A1 (fr) 2011-05-19
AU2010318687A1 (en) 2012-05-24
MX2012004777A (es) 2012-06-01
EP2493293A4 (fr) 2013-03-20
CN102686107A (zh) 2012-09-19
AU2010318687B2 (en) 2016-02-25
JP2013509407A (ja) 2013-03-14
US20120270954A1 (en) 2012-10-25
RU2012122169A (ru) 2013-12-10

Similar Documents

Publication Publication Date Title
MX350951B (es) Composiciones y metodos para tratar enfermedades retinales.
MY151018A (en) Use of nutritional compositions for preventing disorders
MY176679A (en) Use of nutritional compositions for preventing disorders
ECSP099516A (es) Composición suplementaria nutricional para el tratamiento de enfermedades oculares
WO2011053803A3 (fr) Particules biodégradables multifonctionnelles permettant un ciblage sélectionnable, une imagerie, et une administration thérapeutique, et leur utilisation pour le traitement de troubles oculaires
MY192843A (en) Antibodies specific for tgf-beta
MX2019004468A (es) Uso de lentes de contacto en el tratamiento de una afeccion oftalmologica.
WO2010105728A3 (fr) Implant rétinien actif
MX2007008848A (es) Metodos y composiciones para el tratamiento de desordenes oculares.
WO2007136518A3 (fr) Traitement de troubles auto-immunitaires
CL2008003120A1 (es) Compuestos derivados de fenilalquil-, fenilalquenil-, fenilalquinil- amina, feniltioalquilamina, fenilaminoalquilamina, fenilalcoxiamina y fenilalquilguanidina; composicion farmaceutica; y uso de los compuestos para tratar un trastorno o enfermedad oftalmologica tal como retinopatia, maculopatia, retinitis pigmentosa, uveitis, entre otras.
SG156649A1 (en) Crig polypeptide for prevention and treatment of complement-associated disorders
MX2007010752A (es) Usos oftalmicos de moduladores de receptor s1p.
WO2007135426A3 (fr) Traitement de maladies neurodégénératives
WO2007042040A3 (fr) Traitement de retinopathies au moyen d'agonistes de gfr?3
IN2012DN03631A (fr)
WO2013130672A3 (fr) Traitements et diagnostics améliorés du cancer
HK1077306A1 (en) Ocular gene therapy
Poyurovsky Clozapine in treatment-refractory obsessive-compulsive disorder with comorbid schizotypal personality disorder
Kim Hyaluronic acid
Clarke Non-arteritic anterior ischaemic optic neuropathy: case report
Law Intracranial hypertension: case report
De Rojas Bilateral choroidal effusion: case report
Santos-Bueso Sodium aurothiomalate
RU2016131144A (ru) Способы облегчения глазных болезней у псовых